Anti-Human BCAS4 Antibody
Anti-Human BCAS4 Antibody with collaborator-tested evidence for WB, IHC. Read more ›
["WBProduct Description
BCAS4 is the stated target for this antibody product. The listing uses collaborator-supplied technical data from Elabscience and is structured for research-use-only antibody selection through ABMIUM.
Product profile: reactivity: Human; host: Rabbit; clonality: Polyclonal; isotype: IgG; available conjugation options: Unconjugated.
Application evidence: Elabscience lists this product for WB, IHC. In the ABMIUM matrix, these listed applications are marked C to show collaborator-tested ABMIUM Verified evidence. Applications not listed in the supplied data remain marked N.
Technical notes: immunogen: Synthetic peptide of human BCAS4; purification: Affinity purification; concentration: 0.6 mg/mL.
Database references: UniProt: Q8TDM0 | NCBI Gene: 55653.
Research Use Only.
Key Facts
| Target | BCAS4 |
| Also known as | BCAS4, BCAS4/BCAS3 fusion, Breast carcinoma amplified sequence 4, Breast carcinoma amplified sequence 4/3 fusion protein, Breast carcinoma-amplified sequence 4, CNOL, FLJ20495, RP5-1071L10.2 |
| Concentration | 0.6 mg/mL |
| Species reactivity | Human |
| Shelf life | 12 months from shipping dates |
| Research area | Cancer |
| WB | IHC-P | IHC-FR | IF/ICC | FLOW CYT | IP | CHIP | IHC | |
|---|---|---|---|---|---|---|---|---|
| Human |
Specifications
Storage & Stability
Compliance & Certifications
Manufactured under ISO 9001:2015 quality management standards.
Manufactured under ISO 14001:2015 quality management standards.
Manufactured under ISO 45001:2018 quality management standards.
Not intended for diagnostic or therapeutic use.
Substance does not appear on the SVHC candidate list.